Michael J. Yang is EVP and CCO of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 8,059 shares of ACAD, which is worth approximately $138,373. The most recent transaction as insider was on Jan 06, 2021, when has been sold 1,120 shares (Common Stock) at a price of $53.34 per share, resulting in proceeds of $59,741. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.06K
0% 3M change
0% 12M change
Total Value Held $138,373

MICHAEL J. YANG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2021
SELL
Open market or private sale
$59,741 $53.34 p/Share
1,120 Reduced 12.2%
8,059 Common Stock
Jan 06 2021
BUY
Exercise of conversion of derivative security
-
2,722 Added 22.87%
9,179 Common Stock
Oct 16 2020
SELL
Open market or private sale
$53,072 $42.56 p/Share
1,247 Reduced 16.19%
6,457 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
-
2,500 Added 24.5%
7,704 Common Stock

Also insider at

IONS
IONIS PHARMACEUTICALS INC Healthcare
PCRX
Pacira BioSciences, Inc. Healthcare
MJY

Michael J. Yang

EVP and CCO
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD